2023 Poster Presentations


Preliminary List as of November 18, 2022

2bind GmbH
Biophysical Characterizations Supporting Developability and Formulation Screens of Antibodies

908 Devices
Enabling Real-Time Process Control: Automated Glucose Feeding Based on Online Measurement

A-Alpha Bio
ML-Guided Antibody Optimization of a SARS-CoV-2 Binding Antibody Enabled by AlphaSeq

Absolute Antibody
Comparing Potential Bispecific Formats of Trastuzumab and a Humanized OKT3

Absolute Antibody
Prometheus 2.0™: Engineering Manufacturable Humanized Antibodies from Diverse Sources Including Rabbit, Avian and Camelid Antibodies

ACROBiosystems, Inc.
Selection and Evaluation of Ancillary Materials for Cell and Gene Therapy Research

Ajinomoto Co., Inc.
ADC Therapeutic Window Enhancement Based on the Site-Specific Conjugation Platform: AJICAP Conjugation

Ajinomoto Co., Inc.
Novel Format Conjugates and Multi-Specific Antibodies Produced by Chemical Site-Specific Conjugation: AJICAP®

Ajinomoto Co., Inc.
From Peptides and Small Proteins to MAB, Ajinomoto's Proprietary Microbial Platform for Pharmaceutical Protein Production

Automated Plasmid Prep and Optimized Protein Separation Using PhyTip Columns

FairJourney Biologics
Biophysical Characterization Approaches for Developability Assessment in Antibody Discovery

FyoniBio GmbH
Select Your Expression Host Right! - A Comprehensive View on Biopharmaceutical Production in CHOnamite vs Human GEX Host Cell Lines

Immunos Therapeutics
A Stabilized HLA-B57 Open Format (IOS-1002) Binding to LILRB1, LILRB2 and KIR3DL1 Induces Potent Anti-Tumor Efficacy

Immuto Scientific
In Vivo, Rapid Epitope and Paratope Mapping with Single Amino Acid Resolution

Immuto Scientific
In-Vivo Structural Analysis and Epitope Mapping of Membrane Proteins In-Solution with Amino-Acid Resolution and High-Throughput

Institute of Basic Science
Contrastive Learning for Antibody Representations and Antibody Classification Targeting Pathogenic Viruses

Just - Evotec Biologics
Practical Application of Machine-Learned Antibody Discovery Libraries

KANEKA Corporation
Downstream Process Intensification for AAV Using a Novel Impurity Removal Technology

Kyung Hee University
Cytosolic MicroRNA-Inducible Nuclear Translocation of Cas9 Protein for Disease-Specific Genome Modification

A High Performing Easy-to-Use Media and Feed System for CHOK1SV GS-KO® Cell Lines-Based Product Manufacturing

Development of a ddPCR Based Relative Potency Assay for APB-102

National Institutes of Health, National Heart, Lung, and Blood Institute
Expression and Purification of Obp44a with the Aids of LC-MS and NMR

Oswaldo Cruz Foundation (Fiocruz)
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19 After 2 Years of the Pandemic

ProteinSimple, a Bio-Techne brand
High Speed and High Throughput CE-SDS Analysis with the Maurice Turbo CE-SDS Assay

ProteinSimple, a Bio-Techne brand
Novel icIEF Fractionation Coupled with Different MS Systems for Rapid Charge Variant Characterization of Therapeutic Antibodies

RevolKa, Ltd.
Machine-Learning Guided Mutagenesis for Directed Evolution of Recombinant Proteins

Sartorius Stedim Cellca GmbH
Strategies to Remove Single Cell Cloning from Genetic Knock Out Screens in Host Cell Line Engineering

Sogang University
Metal-Mediated Protein Oligomerization Using a Genetic Code Expansion Technique

SoonChunHyang University
Suppression of MyD88- and TRIF-Dependent Signaling Pathways of TLRs by Epoxomicin

Texas A&M University
Thermostable Raman Interaction Profiling (TRIP)

Tosoh Corporation
A Novel Analytical Column Using Adeno-Associated Virus Receptor (AAVR)

U.S. Food and Drug Administration
Size Dependent Toxicity of Engineered Nanoparticle Immunoglobulin Corona in TNFα-Stimulated Endothelial Cells: A Model for Investigation of Protein Particle's Biological Effects

Université catholique de Louvain
A Unique Screening System to Develop E. coli Mutants for the Efficient Production of Difficult to Express Therapeutic Proteins

Wonkwang University
Designing and Immunogenicity Assessment of a Novel mRNA SARS-CoV2 Vaccine Candidate








View By: